中国药房
中國藥房
중국약방
CHINA PHARMACY
2001年
4期
219-220
,共2页
成本-效果分析%调脂药%吉非罗齐%洛伐他汀%多烯康
成本-效果分析%調脂藥%吉非囉齊%洛伐他汀%多烯康
성본-효과분석%조지약%길비라제%락벌타정%다희강
目的：探讨3种调脂药物对高血脂症所产生的经济效果。方法：160例高血脂症患者分别用3种治疗方案：A组用吉非罗齐，B组用洛伐他汀，C组用多烯康。用成本-效果分析方法比较。结果：A组降低TG、TC、LDL-C分别为43％、9％、10％，适合于Ⅱb、Ⅲ、Ⅳ型高血脂症，效果好，经济合理；B组降低TC、LDL-C分别为21％、25％，适用于Ⅱa、Ⅱb型高血脂症，费用低，效果好；C组降低TC、TG分别为17％、28％，适用于TC、TG高的患者。结论：运用药物经济学理论指导临床合理用药，可使有限资源得到合理配置。
目的：探討3種調脂藥物對高血脂癥所產生的經濟效果。方法：160例高血脂癥患者分彆用3種治療方案：A組用吉非囉齊，B組用洛伐他汀，C組用多烯康。用成本-效果分析方法比較。結果：A組降低TG、TC、LDL-C分彆為43％、9％、10％，適閤于Ⅱb、Ⅲ、Ⅳ型高血脂癥，效果好，經濟閤理；B組降低TC、LDL-C分彆為21％、25％，適用于Ⅱa、Ⅱb型高血脂癥，費用低，效果好；C組降低TC、TG分彆為17％、28％，適用于TC、TG高的患者。結論：運用藥物經濟學理論指導臨床閤理用藥，可使有限資源得到閤理配置。
목적：탐토3충조지약물대고혈지증소산생적경제효과。방법：160례고혈지증환자분별용3충치료방안：A조용길비라제，B조용락벌타정，C조용다희강。용성본-효과분석방법비교。결과：A조강저TG、TC、LDL-C분별위43％、9％、10％，괄합우Ⅱb、Ⅲ、Ⅳ형고혈지증，효과호，경제합리；B조강저TC、LDL-C분별위21％、25％，괄용우Ⅱa、Ⅱb형고혈지증，비용저，효과호；C조강저TC、TG분별위17％、28％，괄용우TC、TG고적환자。결론：운용약물경제학이론지도림상합리용약，가사유한자원득도합리배치。
OBJECTIVE: To evaluate the economic effectiveness of three lipid regulation agents in treating patients with hyperlipemia.METHODS: 160 patients with hyperlipemia were divided into three groups: A, B, C.They received different therapeutic shemes: A: gemfibrozil B: lovastatin C: duoxikang.RESULTS: The levels of TG, TC and LDL- C of patients in group A reduced 43%, 9% and 10% respectively, which revealed that gemfibrozil was indicated in Ⅱ b, Ⅲ and Ⅳ hyperlipemia with good effect and low cost.The levels of TC and LDL-C decreased 21% and 25% respectively in group B. Lovastatin was used in Ⅱa, Ⅱb hyperlipemia.The levels of TC and TG declined 17% and 28% respectively in group C.Duoxikang was used in patients with high levels of TC and TG.CONCLUSION: It will improve therapeutic effect and decrease cost, if pharmacoeconomic cost- effectiveness analysis is used to guide rational use of lipid regulation agents in clinical practice.
